Literature DB >> 3071320

Current perspectives on immunology and psychiatry.

M O'Donnell1, D Silove, D Wakefield.   

Abstract

We selectively review recent research findings in the field of psychoimmunology which test the hypotheses that immunological dysfunction may be aetiologically related to mental illnesses such as schizophrenia, and that certain morbid affective states such as depression and other forms of psychosocial distress may be the cause of immunosuppression and through this mechanism affect the outcome of illnesses such as cancer. Our examination of research implicating immunological or infective mechanisms in the aetiology of schizophrenia indicates that most studies have been unable to control for major methodological difficulties but the compatibility of these theories with the dopamine hypothesis suggests that further research attention is warranted. More clearly, there is growing evidence demonstrating a link between depression, other states of psychological distress and immunosuppression, but the clinical significance of these findings remains uncertain. The complex relationship between stress and the outcome of illnesses such as cancer is discussed and the possible implications of these findings for clinical psychiatry are suggested.

Entities:  

Mesh:

Year:  1988        PMID: 3071320     DOI: 10.3109/00048678809161345

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  2 in total

1.  Natural killer cell function in adolescent and adult schizophrenic patients.

Authors:  Franz Resch; G Paul Amminger; Harald Aschauer; Christian Müller; Christoph Zielinski
Journal:  Eur Child Adolesc Psychiatry       Date:  1993-07       Impact factor: 4.785

2.  Thyroid function in clinical subtypes of major depression: an exploratory study.

Authors:  Konstantinos N Fountoulakis; Apostolos Iacovides; Philippos Grammaticos; George St Kaprinis; Per Bech
Journal:  BMC Psychiatry       Date:  2004-03-15       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.